Market Insights report
This market covers drugs to treat the neurological autoimmune disease multiple sclerosis. As there is no cure for multiple sclerosis, the goal is to improve functions after an attack or to prevent attacks. Different types of medication include immunomodulators, immunosuppressants, and interferons. Monoclonal antibodies are now being increasingly used.
What's included?
Due to generic competition, growth in the Multiple Sclerosis Drugs market is only moderate in the considered time span until 2028. The market has been affected negatively by the COVID-19 pandemic because of limited access to healthcare professionals, leading in particular to fewer new patients. As multiple sclerosis treatments are of a long-term nature, revenues are expected to recover only marginally, resulting in a slightly lower forecast level than previously projected.
Overview
Market numbers
We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)